• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高剂量粉末肺部给药的挑战。

Challenges for pulmonary delivery of high powder doses.

机构信息

Department of Pharmaceutical Technology and Biopharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands.

Department of Pharmaceutical Technology and Biopharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands.

出版信息

Int J Pharm. 2018 Sep 5;548(1):325-336. doi: 10.1016/j.ijpharm.2018.07.008. Epub 2018 Jul 2.

DOI:10.1016/j.ijpharm.2018.07.008
PMID:29991452
Abstract

In recent years there is an increasing interest in the pulmonary delivery of large cohesive powder doses, i.e. drugs with a low potency such as antibiotics or drugs with a high potency that need a substantial fraction of excipient(s) such as vaccines stabilized in sugar glasses. The pulmonary delivery of high powder doses comes with unique challenges. For low potency drugs, the use of excipients should be minimized to limit the powder mass to be inhaled as much as possible. To achieve this objective the inhaler design should be adapted to the properties of the API in order to achieve a compatible combination of the drug formulation and inhaler device. The inhaler should have an appropriate powder dosing principle for which prefilled compartments seem most appropriate. The drug formulation should not only allow for accurate filling of these compartments but also enable efficient compartment emptying during inhalation. The dispersion principle must have the capacity to disperse considerable amounts of powder in a short time frame that allows the powder to reach the deep lung. Last, but not least, the inhaler should be simple and intuitive in use, be cost-effective and exhibit accurate and consistent, preferably patient independent, pulmonary delivery performance.

摘要

近年来,人们对大剂量粘性粉末的肺部给药越来越感兴趣,即那些药效低的药物,如抗生素,或药效高的药物,需要用大量赋形剂(如稳定在糖玻璃中的疫苗)来稳定药物。高剂量粉末的肺部给药带来了独特的挑战。对于低效力的药物,应尽量减少赋形剂的使用,以尽可能减少吸入的粉末质量。为了实现这一目标,吸入器的设计应适应 API 的特性,以实现药物配方和吸入器装置的兼容组合。吸入器应采用适当的粉末给药原理,预填充隔室似乎是最合适的。药物配方不仅应允许准确填充这些隔室,而且在吸入过程中还应能够有效地排空隔室。分散原理必须能够在短时间内分散大量粉末,以使粉末到达肺部深处。最后但同样重要的是,吸入器的使用应简单直观,具有成本效益,并具有准确且一致的、最好是患者独立的肺部输送性能。

相似文献

1
Challenges for pulmonary delivery of high powder doses.高剂量粉末肺部给药的挑战。
Int J Pharm. 2018 Sep 5;548(1):325-336. doi: 10.1016/j.ijpharm.2018.07.008. Epub 2018 Jul 2.
2
Dry powders for oral inhalation free of lactose carrier particles.不含乳糖载体颗粒的干粉吸入剂。
Adv Drug Deliv Rev. 2014 Aug;75:32-52. doi: 10.1016/j.addr.2014.04.005. Epub 2014 Apr 13.
3
Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.干粉吸入剂制剂的粉末生产与颗粒工程
Curr Pharm Des. 2015;21(27):3902-16. doi: 10.2174/1381612821666150820111134.
4
Dry powder inhalation: past, present and future.干粉吸入:过去、现在与未来。
Expert Opin Drug Deliv. 2017 Apr;14(4):499-512. doi: 10.1080/17425247.2016.1224846. Epub 2016 Aug 30.
5
Low powder mass filling of dry powder inhalation formulations.干粉吸入制剂的低粉量填充。
Drug Dev Ind Pharm. 2011 Jan;37(1):24-32. doi: 10.3109/03639045.2010.489561. Epub 2010 Aug 12.
6
A review of co-milling techniques for the production of high dose dry powder inhaler formulation.用于生产高剂量干粉吸入剂制剂的共研磨技术综述。
Drug Dev Ind Pharm. 2017 Aug;43(8):1229-1238. doi: 10.1080/03639045.2017.1313858. Epub 2017 Apr 19.
7
Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation.少量的二棕榈酰磷脂酰胆碱可改善喷雾干燥的替莫西林吸入粉雾剂的雾化性能。
Int J Pharm. 2015 Nov 30;495(2):981-90. doi: 10.1016/j.ijpharm.2015.10.019. Epub 2015 Oct 9.
8
Dosing challenges in respiratory therapies.呼吸治疗中的剂量挑战。
Int J Pharm. 2018 Sep 5;548(1):659-671. doi: 10.1016/j.ijpharm.2018.07.007. Epub 2018 Jul 2.
9
The role of disposable inhalers in pulmonary drug delivery.一次性吸入器在肺部药物递送中的作用。
Expert Opin Drug Deliv. 2015 Jan;12(1):143-57. doi: 10.1517/17425247.2014.952626. Epub 2014 Nov 6.
10
The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family.用于肺部递送氨基糖苷类药物的独眼巨人;Twincer™ 家族的新成员。
Eur J Pharm Biopharm. 2015 Feb;90:8-15. doi: 10.1016/j.ejpb.2015.01.012. Epub 2015 Jan 20.

引用本文的文献

1
Emerging for non-invasive heparin delivery systems: recent advances, barriers, solutions, and applicability.新兴的非侵入性肝素递送系统:最新进展、障碍、解决方案及适用性
Saudi Pharm J. 2025 Jun 12;33(3):17. doi: 10.1007/s44446-025-00022-6.
2
Preparation of Carrier-Free Inhalable Dry Powder of Rivaroxaban Using Two-Step Milling for Lung-Targeted Delivery.采用两步研磨法制备用于肺部靶向递送的无载体利伐沙班可吸入干粉
Pharmaceutics. 2025 May 9;17(5):634. doi: 10.3390/pharmaceutics17050634.
3
Formulation and clinical translation of inhalable nanomedicines for the treatment and prevention of pulmonary infectious diseases.
用于治疗和预防肺部感染性疾病的可吸入纳米药物的制剂与临床转化
Drug Deliv Transl Res. 2025 Apr 29. doi: 10.1007/s13346-025-01861-5.
4
Advanced Manufacturing Methods for High-Dose Inhalable Powders.高剂量可吸入粉末的先进制造方法
Pharmaceutics. 2025 Mar 12;17(3):359. doi: 10.3390/pharmaceutics17030359.
5
Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens.抗病毒药物吸入干粉剂:一种治疗呼吸道病毒病原体的有前景的方法。
Viruses. 2025 Feb 12;17(2):252. doi: 10.3390/v17020252.
6
Scale-Up and Postapproval Changes in Orally Inhaled Drug Products: Scientific and Regulatory Considerations.吸入式口服药品的扩大生产及批准后变更:科学与监管考量
J Aerosol Med Pulm Drug Deliv. 2025 Apr;38(2):39-63. doi: 10.1089/jamp.2024.0036. Epub 2024 Dec 9.
7
The Processing Space of the Spray-Dried Mannitol-Leucine System for Pulmonary Drug Delivery.用于肺部药物递送的喷雾干燥甘露醇-亮氨酸系统的加工空间
Pharmaceutics. 2024 Mar 14;16(3):398. doi: 10.3390/pharmaceutics16030398.
8
A phase I clinical trial assessing the safety, tolerability, and pharmacokinetics of inhaled ethanol in humans as a potential treatment for respiratory tract infections.一项I期临床试验,评估吸入乙醇在人体中的安全性、耐受性和药代动力学,将其作为呼吸道感染的一种潜在治疗方法。
Front Med (Lausanne). 2024 Mar 5;11:1324686. doi: 10.3389/fmed.2024.1324686. eCollection 2024.
9
Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements.吸入剂型:聚焦干粉吸入器及其进展
Pharmaceuticals (Basel). 2023 Nov 28;16(12):1658. doi: 10.3390/ph16121658.
10
Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies.儿科药物研发:通过追踪创新疗法审视挑战与机遇。
Pharmaceutics. 2023 Oct 6;15(10):2431. doi: 10.3390/pharmaceutics15102431.